What we do

...the exploration of the conceptual underpinnings of the logic of cost effectiveness,

...the development of advanced evaluation paradigms,

...better understanding of the social value of health care programs.

• Burden of disease studies,
  addressing cancer related burden of disease, attributable cost of illness, and budget impact of interventions, from the perspectives of society as a whole as well as those of payers and patients (focusing on but not limited to Germany);
• Cost value analyses,
  evaluating the cost effectiveness of clinical intervention strategies in cancer care, ranging from new institutional settings (such as comprehensive cancer centers) to novel developments, including the anticipated spread of targeted therapy;
• Economic methods and Social Costs Value Analysis (SCVA),
  contributing to the further improvement of economic evaluation methods within the currently prevailing paradigm of cost effectiveness analyses, and actively participating in the development of health economic evaluation methods designed to better reflect social norms and emphasis on cancer care.

• Education, training, and outreach

This includes:

Health Economics Summer / Winter School

Open Seminars

Collaboration with clinicians: Cost-effectiveness analysis alongside clinical trials

Other activities